Page 1

CM & Minor Owens Owens & Minor Reports 2nd Quarter Financial Results August 3 , 2021 • Record Q2 Earnings : GAAP EPS of $ 0.87 and Adjusted EPS of $ 1.06 • Revenue Growth of 38 % year - over - year • Affirms previously announced 2021 and 2022 guidance RICHMOND , Va .-- ( BUSINESS WIRE ) -- Aug . 3 , 2021-- Owens & Minor , Inc. ( NYSE - OMI ) today reported financial results for the second quarter of 2021 , as summarized in the table below . " We delivered a solid second - quarter , led by outstanding performance in both of our segments . Our results demonstrate the underlying strength of the Global Products segment , and another quarter of improved performance in the Global Solutions segment , " said Edward A. Pesicka , President & Chief Executive Officer of Owens & Minor . " Our business blueprint continues to be the framework that helps drive our results as we begin to return to a more typical operating environment and helps us to achieve our long - term financial targets . " Pesicka added , " Our strong performance in the first half , and improved line of sight toward the remainder of 2021 allows us to maintain the range of our full - year guidance for adjusted EPS of $ 3.75 to $ 4.25 and adjusted EBITDA of $ 450 million to $ 500 million . In addition , we affirm our previously announced 2022 guidance . " " I am immensely proud of what our teammates have accomplished as we continue to execute on our strategic priorities to deliver sustainable growth and value for all our stakeholders , " Pesicka concluded . Financial Summary ( 1 ) ( $ in millions , except per share data ) Revenue Operating Income , GAAP Adj . Operating Income , Non - GAAP Income ( Loss ) from continuing operations , GAAP Adj . Net Income , Non - GAAP Adj . EBITDA , Non - GAAP Income ( Loss ) from continuing operations per share , GAAP 2Q21 $ 2,489 $ 96.9 • 38 % Revenue growth year - over - year driven by : $ 115.5 $ 65.9 $ 80.1 • Balance Sheet $ 127.7 $ 0.87 $ 1.06 o $ 77 million increase in adjusted operating income or 3 times the prior year o $ 10 million or 47 % decrease in interest expense • Adjusted net income per share was over 5 times the prior year o Effective response to the ongoing recovery of elective procedures o Higher sales of PPE 2Q20 $ 1,808 o Pass - through of elevated glove costs o Continued strong performance in our Patient Direct business $ 22.2 $ 38.9 $ 0.2 $ 12.5 $ 52.1 YTD 2021 $ 0.20 $ 4,816 $ 243.6 $ 278.2 $ 135.5 $ 191.5 $ 303.2 $ 1.80 Adj . Net income per share , Non - GAAP ( 2 ) ( 1 ) Financial results relate to continuing operations . Reconciliations of the differences between the non - GAAP financial measures presented in this release and their most directly comparable GAAP financial measures are included in the tables below . ( 2 ) Adjusted net income per share , Non - GAAP for 2Q21 was unfavorably impacted as compared to prior year by foreign currency translation in the amount of $ 0.02 and , favorably impacted by $ 0.03 for the 2021 year - to - date period . 2nd Quarter 2021 Highlights YTD 2020 $ 2.54 $ 3,930 $ 33.0 $ 66.3 ( $ 8.7 ) • Substantial increase in year - over - year second quarter earnings driven by revenue growth , market dynamics , product mix , and operating efficiencies o 117 basis point gross margin expansion $ 14.9 $ 92.7 ( $ 0.14 ) $ 0.24